Stable Differences in Intrinsic Mitochondrial Membrane Potential of Tumor Cell Subpopulations Reflect Phenotypic Heterogeneity

Heterogeneity among cells that constitute a solid tumor is important in determining disease progression. Our previous work established that, within a population of metastatic colonic tumor cells, there are minor subpopulations of cells with stable differences in their intrinsic mitochondrial membrane potential (ΔΨm), and that these differences in ΔΨm are linked to tumorigenic phenotype. Here we expanded this work to investigate primary mammary, as well as colonic, tumor cell lines. We show that within a primary mammary tumor cell population, and in both primary and metastatic colonic tumor cell populations, there are subpopulations of cells with significant stable variations in intrinsic ΔΨm. In each of these 3 tumor cell populations, cells with relatively higher intrinsic ΔΨm exhibit phenotypic properties consistent with promotion of tumor cell survival and expansion. However, additional properties associated with invasive potential appear in cells with higher intrinsic ΔΨm only from the metastatic colonic tumor cell line. Thus, it is likely that differences in the intrinsic ΔΨm among cells that constitute primary mammary tumor populations, as well as primary and metastatic colonic tumor populations, are markers of an acquired tumor phenotype which, within the context of the tumor, influence the probability that particular cells will contribute to disease progression.

[1]  Paolo Vineis,et al.  Cell selection as driving force in lung and colon carcinogenesis. , 2010, Cancer research.

[2]  King-Jen Chang,et al.  Effects of Monascus-Fermented Rice Extract on Malignant Cell—Associated Neovascularization and Intravasation Determined Using the Chicken Embryo Chorioallantoic Membrane Model , 2010, Integrative cancer therapies.

[3]  Lani F. Wu,et al.  Cellular Heterogeneity: Do Differences Make a Difference? , 2010, Cell.

[4]  D. Dressman,et al.  Heteroplasmic mitochondrial DNA mutations in normal and tumor cells , 2010, Nature.

[5]  D. Turnbull,et al.  Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations , 2010, Brain : a journal of neurology.

[6]  Keshav K. Singh,et al.  mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice , 2009, Journal of Human Genetics.

[7]  Keshav K. Singh,et al.  Cancer cell mitochondria confer apoptosis resistance and promote metastasis , 2009, Cancer biology & therapy.

[8]  Xinmin Cao,et al.  GRIM-19 is essential for maintenance of mitochondrial membrane potential. , 2008, Molecular biology of the cell.

[9]  I. Hassinen,et al.  Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates , 2007, Journal of Biological Chemistry.

[10]  C. Chi,et al.  Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion. , 2007, Mitochondrion.

[11]  Josephine C. Adams,et al.  Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas , 2006, BMC Cancer.

[12]  J. P. McCoy,et al.  The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity* , 2006, Journal of Biological Chemistry.

[13]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[14]  J. Smeitink,et al.  Mitochondrial complex I: Structure, function and pathology , 2006, Journal of Inherited Metabolic Disease.

[15]  D. Fishman,et al.  Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. , 2006, Cancer letters.

[16]  L. Augenlicht,et al.  Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential. , 2006, Cancer research.

[17]  L. Augenlicht,et al.  The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. , 2005, Cancer research.

[18]  J R Griffiths,et al.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.

[19]  P. Beaune,et al.  Clinical value of mitochondrial mutations in colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Nanko,et al.  Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder. , 2004, Genomics.

[22]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[23]  M. Schlame,et al.  Remodeling of Cardiolipin by Phospholipid Transacylation* , 2003, Journal of Biological Chemistry.

[24]  S. Dimauro,et al.  Phospholipid abnormalities in children with Barth syndrome. , 2003, Journal of the American College of Cardiology.

[25]  N. Koshikawa,et al.  Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model , 2003, Oncogene.

[26]  Ronald J A Wanders,et al.  Only One Splice Variant of the Human TAZ Gene Encodes a Functional Protein with a Role in Cardiolipin Metabolism* , 2003, Journal of Biological Chemistry.

[27]  Andrew J. Wilson,et al.  The intrinsic mitochondrial membrane potential (Deltapsim) is associated with steady-state mitochondrial activity and the extent to which colonic epithelial cells undergo butyrate-mediated growth arrest and apoptosis. , 2003, Cancer research.

[28]  R. Carroll,et al.  Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. , 2002, Carcinogenesis.

[29]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[30]  Luca Scorrano,et al.  A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. , 2002, Cancer cell.

[31]  J. Mariadason,et al.  Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (deltapsim). , 2000, Cancer research.

[32]  J. Mariadason,et al.  Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. , 2000, Cancer research.

[33]  M. L. Greenberg,et al.  Absence of Cardiolipin in the crd1 Null Mutant Results in Decreased Mitochondrial Membrane Potential and Reduced Mitochondrial Function* , 2000, The Journal of Biological Chemistry.

[34]  N. Uesugi,et al.  Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. , 2000, Gastroenterology.

[35]  R. Kucherlapati,et al.  Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. , 1999, Cancer research.

[36]  J. Mariadason,et al.  Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[37]  P. Vreken,et al.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060) , 1999, Journal of Inherited Metabolic Disease.

[38]  L. Augenlicht,et al.  Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity. , 1999, Cancer research.

[39]  Bert Vogelstein,et al.  Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.

[40]  T. Sugai,et al.  Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: Evidence for mismatch repair systems in mitochondrial genome , 1998, Oncogene.

[41]  L. Augenlicht,et al.  Mitochondrial Membrane Potential (ΔΨmt) in the Coordination of p53-independent Proliferation and Apoptosis Pathways in Human Colonic Carcinoma Cells , 1998 .

[42]  Y. Oshika,et al.  © 1998 Cancer Research Campaign , 2022 .

[43]  G. Mazzacca,et al.  Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. , 1996, Gastroenterology.

[44]  M. Mandal,et al.  Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[45]  K. Mimori,et al.  Overexpression of matrix metalloproteinase‐7 mRNA in human colon carcinomas , 1995, Cancer.

[46]  Jack P. Witty,et al.  Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. , 1994, Cancer research.

[47]  L. Augenlicht,et al.  Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. , 1994, Cancer research.

[48]  J. Lupton,et al.  Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. , 1994, Cancer letters.

[49]  P. Gibson,et al.  Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. , 1993, Gut.

[50]  L. Augenlicht,et al.  Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. , 1991, The Journal of biological chemistry.

[51]  G. Ronco,et al.  New stable butyrate derivatives alter proliferation and differentiation in human mammary cells , 1991, International journal of cancer.

[52]  T. Smith,et al.  J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. , 1991, Biochemistry.

[53]  J. Modica-Napolitano,et al.  Aberrant mitochondria in two human colon carcinoma cell lines. , 1989, Cancer research.

[54]  W. Roediger Bacterial short‐chain fatty acids and mucosal diseases of the colon , 1988, The British journal of surgery.

[55]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[56]  E. Kurschel,et al.  Clinical pharmacology of sodium butyrate in patients with acute leukemia. , 1987, European journal of cancer & clinical oncology.

[57]  T. Lampidis,et al.  Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. , 1985, The Journal of biological chemistry.

[58]  G. Azzone,et al.  'Cross-talk' between redox- and ATP-driven H+ pumps. , 1984, Biochemical Society transactions.

[59]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[60]  J. Cummings FERMENTATION IN THE HUMAN LARGE INTESTINE: EVIDENCE AND IMPLICATIONS FOR HEALTH , 1983, The Lancet.

[61]  I. Summerhayes,et al.  Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[62]  W. Roediger Utilization of nutrients by isolated epithelial cells of the rat colon. , 1982, Gastroenterology.

[63]  A. Leibovitz,et al.  Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.

[64]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[65]  P. Goldman The carbon-fluorine bond in compounds of biological interest. , 1969, Science.

[66]  P. Ms,et al.  THE SPECIALTY OF MEDICAL ADMINISTRATION. , 1965 .

[67]  W. E. W. ROEDlGER Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man , 2006 .

[68]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[69]  T. Ishikawa,et al.  Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin , 2004, Clinical & Experimental Metastasis.

[70]  Josephine C. Adams,et al.  Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. , 2003, The American journal of pathology.

[71]  G.,et al.  Effects of Fatty Acids on Expression of Genes Encoding Subunits of Cytochrome c Oxidase and Cytochrome c Oxidase Activity in HT 29 Human Colonic Adenocarcinoma Cells * , 2001 .

[72]  Wim H. M. Saris,et al.  Proceedings of the American Association for Cancer Research. , 2001 .

[73]  F. González,et al.  Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. , 1998, JPEN. Journal of parenteral and enteral nutrition.

[74]  H. Schulz Oxidation of fatty acids , 1996 .

[75]  G. Singh,et al.  Energetic characteristics of cisplatin resistant ovarian carcinoma cells. , 1996, Anticancer research.

[76]  L. B. Chen,et al.  Mitochondrial membrane potential in living cells. , 1988, Annual review of cell biology.

[77]  J. Wong,et al.  Recent Advances in the Study of Mitochondria in Living Cells , 1988 .

[78]  A. Ravid,et al.  Effect of polar organic compounds on leukemic cells: Butyrate‐induced partial remission of acute myelogenous leukemia in a child , 1983, Cancer.

[79]  K. Sepkowitz,et al.  A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma. , 1981, Laboratory investigation; a journal of technical methods and pathology.